Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05811143 · ClinicalTrials.gov registry record
Examining the Effects of Dorsal Column Stimulation on Pain From Lumbar Spinal Stenosis Related to Epidural Lipomatosis.
A clinical trial, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- 3
- Enrollment target
NCT05811143: Completed study, sponsored by University Hospitals Cleveland Medical Center.
NCT05811143 is a clinical trial that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05811143 has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- 3 participants
- Enrollment target
Study Summary
The specific aims of this proposal are to: Examining the effects of dorsal column stimulation on pain from lumbar spinal stenosis related to lumbar epidural lipomatosis. The primary outcome will be improvement in VAS score of combined back and leg pain at 6 weeks follow-up. Secondary outcomes will include improvement in Visual Analog Scale (VAS) back pain scores, VAS leg pain scores, and Oswestry Disability Index (ODI) , as well as SCS complication rate. The specific aims of this proposal are to: Examining the effects of dorsal column stimulation on pain from lumbar spinal stenosis related to lumbar epidural lipomatosis. The primary outcome will be improvement in VAS score of combined back and leg pain at 6 weeks follow-up. Secondary outcomes will include improvement in VAS back pain scores, VAS leg pain scores, and Oswestry Disability Index, as well as SCS complication rate.
Primary Outcome
0 meaning No Pain, 10 being worst possible pain. Higher pain means worse outcome.
Interventions
- DEVICE Spinal Cord Stimulator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2020-09-22 |
| Est. Completion | 2024-01-25 |
What the finished NCT05811143 record still lists
NCT05811143 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Spinal Cord Stimulator is the first listed.
NCT05811143 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05811143 about?
NCT05811143 is a clinical study titled "Examining the Effects of Dorsal Column Stimulation on Pain From Lumbar Spinal Stenosis Related to Epidural Lipomatosis.". The specific aims of this proposal are to: Examining the effects of dorsal column stimulation on pain from lumbar spinal stenosis related to lumbar epidural lipomatosis. The primary outcome will be improvement in VAS score of combined back and leg pain at 6 weeks follow-up. Secondary outcomes will ...
What is the current status of trial NCT05811143?
This trial is currently completed. The enrollment target is 3 participants. The study started on 2020-09-22. Estimated completion is 2024-01-25.
What interventions are being tested in trial NCT05811143?
The interventions under investigation include: Spinal Cord Stimulator (DEVICE).
Who is sponsoring clinical trial NCT05811143?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI